Abstract
Get full access to this article
View all access options for this article.
References
1.
Tomlins
et al. Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples . JCO Precis Oncol . 2021 ; 5 :1312 –1324
2.
Guardant360® CDx Technical Information (Accessed 09-21-21)
3.
Shaw
et al. ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer . J Clin Oncol . 2019 ; 37 (16 ):1370 –1379
4.
FoundationOne® Liquid CDx (F1 Liquid CDx) SSED. (Accessed 09-22-21)